CompoAtlas

Clove in Jojoba Oil

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Syzygium aromaticum

Source : Syzygium aromaticum - Bourgeon floral

30 Pour cent

Non-medicinal ingredients

Huile de jojoba

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 2 Goutte(s) ; maximum: 12 Goutte(s)minimum: 1 Tous les jours ; maximum: 3 Tous les jours

Uses authorised in Canada

Used in aromatherapy to help relieve joint and muscle pain associated with strain, and to help relieve colds.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Clove 30% in Jojoba Oil 5ml
Licence holder
Essential Nature Inc.
NPN or DIN-HM
80084373
Status
Active licence
Licence date
10 April 2018
Revision date
Not provided
Form
Liquide
Route of administration
Topique
Application type
Officinale

Source

Official Health Canada record, licence 80084373

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Clove in Jojoba Oil (Essential Nature Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80084373-clove-in-jojoba-oil, updated 10 April 2018.

Enter to analyse, Shift+Enter for a new line